1Patrono C, Patrignani P, Luis A, et al. Cyclooxygenase-selective inhibition of prostanoid formation:transducing biochemical selectivity into clinical read-outs[ J]. J Clin Invest,2001,108( 1 ) :7-13.
2Tucker ON, Dannenberg A J, Yang ER, et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer [ J ]. Cancer Res,1999,59 (5) :987-990.
3Masferrer JL, Leahy KM, Koki A, et al. Antiangeogenic and antitumor activities of cyclooxygenase-2 inhibitors [ J ]. Cancer Res, 2000,60(5) :1306-1311.
4Uefuji K, Ichikura T, Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer[J]. Clin Cancer Res,2000,6( 1 ) : 135-138.
6Marrogi AJ, Travls WD, Wdsh JA, et al. Nitric oxide synthase, cyclooxygcnase-2 and vascular endothdial growth factor in the angiogenesis of non-small cell lung carcinoma [J]. Clin Cancer Res,2000,6(12) :4739-4748.
7Liu XH, Kirschenbaum A,Yao S, et al. Inhibition of cyclooxygenase-2 suppress angiogenesis and the growth of prostate cancex in vivo[J]. J Urol,2000,164 (3) :820-825.
8Liu XH, Kirschenbaum A, Yao S, et al. Up-regulation of VEGF by cobalt chloride-simulated hypoxia is mediated by persistent induction of COX-2 in a metastatic human prostate cancer cell lines[J]. J Exp Metastasis, 1999,17 (8) :687-694.
9Shigeta J, Takahashi S, Okabe S. Role of cyclooxygenase-2 in the healing of gastric ulcers in rats [ J ]. J Phil Exp Ther, 1998,286(3) :1383-1390.
10Hull MA, Thomson JL, Hawkey CJ. Expression of cyclooxygenase-1 and 2 by human gastric endothelial cells [ J ]. Gut, 1999,45 ( 4 ) :529-536.
同被引文献33
1Yun-Lin Wu~1 Bo Sun~1 Xue-Jun Zhang~2 Sheng-Nian Wang~2 Heng-Yi He~2 Min-Min Qiao~1 Jie Zhong~1 Jia-Yu Xu~1 1 Department of Gastroenterology,Ruijin Hospital,Shanghai Second Medical University,Shanghai 200025,China2 Institude of Biochemistry and Cell Biology,Shanghai Institues for Biological Sciences,Chinese Academy of Sciences.Shanghai 200025,China.Growth inhibition and apoptosis induction Sulindac on Human gastric cancer cells[J].World Journal of Gastroenterology,2001,7(6):796-800. 被引量：64
5Bresalier RS, Sandier RS, Quan H, etal. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial[J].N Engl J Med, 2005, 352(11) : 1092- 1102.
6Solomon SD, McMurray JV, Pfefer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention [J]. N Engl J Med, 2005, 352 (11): 1071-1080.
7Castro MR, Edelman JL, et al. Effect of COX inhibitor on VEGF2 induced retinal vascular leakage and experimental corneal and choroidal neovascularization[J].Exp Eye Res, 2004, 79(2): 275-285.
8Buerkle MA, Lehrer S, Sohn HY, et al. Selective Inhibition of eyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo [J]. Circulation, 2004, 110 (14) : 2053-2059.
9Aw TJ, Haas SJ, Liew D, et al. Meta-analysis of cyclooxygenase-2 inhihitors and their effects on blood pressure [J]. Arch Intern Med, 2005, 165 (5): 490-496.
10Sowers JR, White WB, Pitt B, et al. The effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus [J]. Arch Intern Med, 2005, 165 (2):161-168.
